Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.

MLA

Niesvizky, Ruben, et al. “Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 33, no. 33, Nov. 2015, pp. 3921–29. EBSCOhost, https://doi.org/10.1200/JCO.2014.58.7618.

APA

Niesvizky, R., Flinn, I. W., Rifkin, R., Gabrail, N., Charu, V., Clowney, B., Essell, J., Gaffar, Y., Warr, T., Neuwirth, R., Zhu, Y., Elliott, J., Esseltine, D.-L., Niculescu, L., & Reeves, J. (2015). Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 33(33), 3921–3929. https://doi.org/10.1200/JCO.2014.58.7618

Chicago

Niesvizky, Ruben, Ian W Flinn, Robert Rifkin, Nashat Gabrail, Veena Charu, Billy Clowney, James Essell, et al. 2015. “Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33 (33): 3921–29. doi:10.1200/JCO.2014.58.7618.